First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity
about
Oncolytic viruses: finally deliveringReplication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical DataViruses as nanomedicine for cancerTrial Watch-Oncolytic viruses and cancer therapyDeletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models.Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future PerspectivesAssessment of current virotherapeutic application schemes: "hit hard and early" versus "killing softly"?CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy.Oncolytic Virus-Mediated Targeting of PGE2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy.Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancerPhase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers.Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression.Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy.Replicating poxviruses for human cancer therapy.Oncolytic viruses-immunotherapeutics on the rise.Oncolytic viruses: emerging options for the treatment of breast cancer.A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol.Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus.Review: Oncolytic virotherapy, updates and future directions.Full Genome Sequence of the Western Reserve Strain of Vaccinia Virus Determined by Third-Generation Sequencing.Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus.Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic PotencySuperagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 BlockadeModifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2
P2860
Q26772039-5763B141-25FB-4DE0-8FFF-01E1ABF827E7Q26801501-4DB58B5F-D15E-429B-80EA-C9470F4FB697Q27690636-410D1950-59A6-4EAD-B2CF-069F47760804Q28072347-E5946F65-9544-4ACB-B823-3D2F8D3CDA6EQ33625843-2011DDC6-D80B-4FA7-ACB5-8380B5CE2B39Q33679505-99B8C990-407A-415A-A898-043699E04CE8Q36664268-99A58E1E-1237-4FC0-B94C-4A4A2D9CB05CQ36821243-5CBDA6F5-0D86-4D6E-A463-937996AC6D55Q37129177-7AA6386C-500A-4F78-9AC7-0459AA0A18D1Q37225501-75E302A2-90A1-498A-BEE4-D8A0DB4CB743Q37256174-16962E4F-6A65-4C30-A9FD-6E76B596BC57Q37681801-CF08EA93-C1AF-4B55-AB6B-CFCCDB6F34B2Q37687542-D3905134-2B9D-4E31-8C37-5B4766DE3A22Q37736296-E35F9A62-BB01-42AF-9283-5A6486E6C5B6Q38407351-36E7D51B-E64D-4F30-8D8A-546BC31ED9BEQ38919107-00622E1D-ED5E-4F3F-A328-F139F8F2D2B9Q39129326-5C631C02-10BA-48E8-A049-7F9D8352E344Q40066397-DDBE87AD-D5E0-4316-8D5B-69B110EAC91DQ41919532-883F164B-51F0-4A2B-BA77-0A48A0038A87Q45325487-92BC82BC-A287-4373-9B57-CDF01223A968Q47160989-2CC9E2EC-9535-48C4-AA30-7F66EA76116DQ52353901-64110390-926C-425A-B730-1809BB1F46C7Q55051893-2AFA874C-4197-400A-9D3E-0DF3AF114E9DQ56889716-32EFD54F-7549-428F-BE35-688CFFC085A2Q56967396-7CF5F824-A9D2-46AA-8E73-7FD9FF2F431DQ58586410-AE2D07A0-997F-4FFD-943E-BAFA15343EB8
P2860
First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
First-in-man study of western ...... spread, and antitumor activity
@ast
First-in-man study of western ...... spread, and antitumor activity
@en
type
label
First-in-man study of western ...... spread, and antitumor activity
@ast
First-in-man study of western ...... spread, and antitumor activity
@en
prefLabel
First-in-man study of western ...... spread, and antitumor activity
@ast
First-in-man study of western ...... spread, and antitumor activity
@en
P2093
P2860
P356
P1433
P1476
First-in-man study of western ...... spread, and antitumor activity
@en
P2093
Caroline J Breitbach
David H Kirn
David L Bartlett
Eva Wieckowski
Heather L Jones
Herbert J Zeh
J Andrea McCart
Lekshmi Ramalingam
P2860
P304
P356
10.1038/MT.2014.194
P50
P577
2014-10-08T00:00:00Z